Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This study evaluated the efficacy and safety of fixed-dose combinations of Sitagliptin and Empagliflozin in patients with inadequately controlled Type 2 Diabetes, showing significant reductions in HbA1c and body weight.
Curcumin supplementation significantly improved liver steatosis and metabolic parameters in obese patients with type 2 diabetes.
This study evaluated the impact of ozonated gel application alongside scaling and root planing in diabetic patients with stage III periodontitis, finding significant improvements in clinical outcomes.
BL21 probiotic added to metformin in adults with type 2 diabetes.
Gamified mHealth app (DiaSocial) for diabetes management in older veterans with poorly controlled Type 2 diabetes.
The Few Touch Application (FTA) was evaluated as a mHealth intervention for diabetes self-management, showing a significant reduction in HbA1c levels among long-term users.
This study compared the efficacy and safety of azelnidipine and trichlormethiazide in treating hypertension in type 2 diabetic patients. Both medications showed similar changes in HbA1c levels, but azelnidipine demonstrated greater reductions in blood pressure.
This study investigated the effects of Bifidobacterium animalis subsp. lactis TISTR 2591 on metabolic parameters in adults with Type 2 Diabetes, finding significant improvements in fasting blood glucose and insulin resistance.
This study explored the impact of a low-carbohydrate, energy-restricted diet on beta-cell function and liver fat in adults with Type 2 diabetes, finding significant reductions in liver fat and insulin resistance.
This study investigated the effects of semaglutide on vascular and liver function in patients with type 2 diabetes and nonalcoholic fatty liver disease, finding significant improvements in various health markers.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
